Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion

Patients with hypersensitive gut mucosa often suffer from food intolerances (FIs) associated with an inadequate gastrointestinal function that affects 15–20% of the population. Current treatments involve elimination diets, but require careful control, are difficult to maintain long-term, and diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardizzone, Alessio, Lanza, Marika, Casili, Giovanna, Campolo, Michela, Paterniti, Irene, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182885/
https://www.ncbi.nlm.nih.gov/pubmed/35684051
http://dx.doi.org/10.3390/nu14112251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182885/
https://www.ncbi.nlm.nih.gov/pubmed/35684051
http://dx.doi.org/10.3390/nu14112251

Ejemplares similares